Prevymis (letermovir) - Merck (MSD)
https://programme.aids2026.org/Abstract/DesktopAbstractDetail/?abstractid=8159
 
S. Isnard1,2; L. Royston1,2,3; T. Mabanga1,2; H. Traoré4; A. Pagliuzza4; C.A. Berini1,2; J. Girouard1,2; T. Bessissow1,5; P.L. Lakatos1,5; C.T. Costiniuk1,2; B. Lebouché1,2; R. Fromentin4; N. Chomont4; J.-P. Routy1,2,6
 
May 3, 2026
 
Prev Next